Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive antiviral immunity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 52, 2010, Pages 22647-22652

  Chang, W L William ^a   Barry, Peter A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Immune evasion; Monkey model

Indexed keywords

INTERLEUKIN 10;

ADAPTIVE IMMUNITY; ARTICLE; CELL MANIPULATION; CYTOMEGALOVIRUS; GENETIC VARIABILITY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IN VITRO STUDY; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; VIRUS ATTENUATION; VIRUS IMMUNITY;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOMEGALOVIRUS; DENDRITIC CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-10; LECTINS, C-TYPE; LIPOPOLYSACCHARIDES; LYMPH NODES; MACACA MULATTA; MACROPHAGES; MALE; MICROSCOPY, FLUORESCENCE; MUTATION; VIRAL PROTEINS;

CERCOPITHECINE HERPESVIRUS 8; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5; MACACA MULATTA;

EID: 78651102604     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1013794108     Document Type: Article

References (36)

1. Sylwester AW, et al. (2005) Broadly targeted human cytomegalovirus- specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202:673-685.
2. Dunn W, et al. (2003) Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci USA 100:14223-14228.
3. Crough T, Khanna R (2009) Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 22:76-98.
4. Lockridge KM, et al. (2000) Primate cytomegaloviruses encode and express an IL-10-like protein. Virology 268:272-280.
5. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S (2000) Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci USA 97:1695-1700.
6. Jones BC, et al. (2002) Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. Proc Natl Acad Sci USA 99:9404-9409.
7. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765.
8. Spencer JV, et al. (2002) Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 76:1285-1292.
9. Chang WL, Baumgarth N, Yu D, Barry PA (2004) Human cytomegalovirus- encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J Virol 78:8720-8731.
10. Raftery MJ, et al. (2004) Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J Immunol 173:3383-3391.
11. Chang WL, Barry PA, Szubin R, Wang D, Baumgarth N (2009) Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 390:330-337.
12. Chang WL, et al. (2007) Exposure of myeloid dendritic cells to exogenous or endogenous IL-10 during maturation determines their longevity. J Immunol 178:7794-7804.
13. Spencer JV, Cadaoas J, Castillo PR, Saini V, Slobedman B (2008) Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10. Virology 374:164-169.
14. Barry PA, Chang WL (2007) Primate Betaherpesviruses. Human Herpesviruses: Biology, Therapy and Immunoprophylaxis, eds Arvin A, et al. (Cambridge University Press, Cambridge), pp 1051-1075.
15. Hansen SG, et al. (2010) Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 328:102-106.
16. Chang WL, Barry PA (2003) Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis. J Virol 77:5073-5083.
17. Muyrers JP, Zhang Y, Testa G, Stewart AF (1999) Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res 27:1555-1557.
18. Grangeot-Keros L, et al. (1997) Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis 175:944-946.
19. Sozzani S, et al. (1998) Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med 187:439-444.
20. Ibanez CE, Schrier R, Ghazal P, Wiley C, Nelson JA (1991) Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 65:6581-6588.
21. Sinzger C, Plachter B, Grefte A, The TH, Jahn G (1996) Tissue macrophages are infected by human cytomegalovirus in vivo. J Infect Dis 173:240-245.
22. Andrews DM, Andoniou CE, Granucci F, Ricciardi-Castagnoli P, Degli-Esposti MA (2001) Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol 2:1077-1084.
23. Kvale EO, et al. (2006) CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection. Blood 107:2022-2029.
24. Jego G, et al. (2003) Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19:225-234.
25. Boppana SB, Britt WJ (1995) Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis 171:1115-1121.
26. Jonjić S, et al. (1994) Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 179:1713-1717.
27. Hsu DH, et al. (1990) Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250:830-832.
28. Liu Y, et al. (1997) The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J Immunol 158:604-613.
29. Cavanaugh VJ, Deng Y, Birkenbach MP, Slater JS, Campbell AE (2003) Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland. J Virol 77:1703-1717.
30. Humphreys IR, et al. (2007) Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands. J Exp Med 204:1217-1225.
31. Brooks DG, et al. (2006) Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12:1301-1309.
32. Kaplan DE, et al. (2008) Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis. J Hepatol 48:903-913.
33. Alter G, et al. (2010) IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection. J Clin Invest 120:1905-1913.
34. Ubol S, Phuklia W, Kalayanarooj S, Modhiran N (2010) Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. J Infect Dis 201:923-935.
35. Slobedman B, Barry PA, Spencer JV, Avdic S, Abendroth A (2009) Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J Virol 83:9618-9629.
36. Cunningham C, et al. (2010) Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens. J Gen Virol 91:605-615.